3.3. Receiver Operating Characteristic (ROC) Curve for Using BTLA, CD27, CD70, CD28 and CD80 Distinguishing between Ovarian Cancer and Benign Ovarian Lesion. This evidence concerns the gene CD80 and ovarian cancer.